Compare Aecom (ACM) vs Novartis AG (NVS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Aecom vs Novartis AG — how do they compare? Aecom trades at $67.13 (market cap $8.62B), while Novartis AG trades at $152.33 (market cap $295.37B). The key difference: Novartis AG is far larger — about 34.3× Aecom's market cap, and Novartis AG pays the higher dividend (3.07%). Which is the better fit depends on your goals.
| ACM | NVS | |
|---|---|---|
Market Cap | $8.62B | $295.37B |
Sector | Industrials | Health |
52-Week High | $134.35 | $168.62 |
52-Week Low | $66.86 | $119.31 |
Enterprise Value | $10.81B | $336.69B |
Dividend Yield | 1.77% | 3.07% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Aecom
Aecom is one of the largest global providers of design, engineering, construction, and management services. The firm serves a broad spectrum of end markets including infrastructure, water, transportation, and energy. Based in Los Angeles, Aecom has a presence in over 150 countries and employs 51,000. The company generated $13.3 billion in sales and $701 million in adjusted operating income in fiscal 2021.
Read more on ACM →About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →
